Alx Oncology Holdings earnings were -$80.9M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ALXO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$18.0M, up 0.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ALXO reported annual earnings of -$101.7M, with -24.6% growth. The next ALXO earnings date is Nov 6, 2026.
Alx Oncology Holdings Earnings Reports & History FAQ
What were Alx Oncology Holdings's earnings last quarter?
On ALXO's earnings call on Aug 11, 2026, Alx Oncology Holdings (NASDAQ: ALXO) reported Q2 2026 earnings per share (EPS) of -$0.13, up 73.47% year over year. Total ALXO earnings for the quarter were -$17.97 million. In the same quarter last year, Alx Oncology Holdings's earnings per share (EPS) was -$0.49.
The next ALXO earnings date is Nov 6, 2026. Add ALXO to your watchlist to be reminded of Alx Oncology Holdings's next earnings date.
Is Alx Oncology Holdings profitable or losing money?
As of the last Alx Oncology Holdings earnings report, Alx Oncology Holdings is currently losing money. Alx Oncology Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$80.89 million, a 30.61% decrease year over year.
What was ALXO's earnings growth in the past year?
As of Alx Oncology Holdings's earnings date in Aug 11, 2026, Alx Oncology Holdings's earnings has grown year over year. ALXO earnings in the past year totalled -$80.89 million.
What are Alx Oncology Holdings's earnings expectations?
The current EPS estimate for Alx Oncology Holdings's earnings report in Nov 6, 2026 is -$0.14.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.